Sourcebio International Plc (LON:SBI – Get Free Report)’s share price traded up 4.5% during trading on Wednesday . The company traded as high as GBX 125 ($1.59) and last traded at GBX 115 ($1.46). 1,571,282 shares were traded during mid-day trading, an increase of 931% from the average session volume of 152,444 shares. The stock had previously closed at GBX 110 ($1.40).
Sourcebio International Trading Up 4.5 %
The firm has a market capitalization of £85.31 million and a price-to-earnings ratio of 1,277.78. The company has a debt-to-equity ratio of 35.10, a quick ratio of 1.78 and a current ratio of 1.91. The company has a 50 day moving average price of GBX 115 and a two-hundred day moving average price of GBX 115.
About Sourcebio International
Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally. The company's services cover histopathology cancer screening and clinical diagnostic services; DNA sequencing services and precision medicine to pharmaceutical and biotechnology companies, academia, contract research organizations, and other research markets; shelf-life testing services and equipment; and COVID-19 antigen PCR testing services.
See Also
- Five stocks we like better than Sourcebio International
- What Are Dividend Challengers?
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3 Penny Stocks Ready to Break Out in 2025
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Sourcebio International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sourcebio International and related companies with MarketBeat.com's FREE daily email newsletter.